- Voyage is the first-ever Phase 3 study of lysergide D-tartrate (LSD) with the primary endpoint measuring the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A) score at week 12 for ...
Findings showed the 100mcg dose met the primary endpoint demonstrating a statistically significant 7.6-point reduction in HAM-A score at week 4 compared with placebo. The Food and Drug Administration ...
In a recent study published in the JAMA Journal, researchers from the United States (U.S.) reviewed the risks and benefits of anxiety screening and treatment. Recent studies indicate that anxiety is ...
Mental health professionals use specific criteria to identify anxiety disorders. Learn how the DSM guides the diagnostic process and why it matters for your care. The Diagnostic and Statistical Manual ...
In a recent study published in the JAMA Journal, researchers examined the different aspects of screening for anxiety disorders in adults. Study: Screening for Anxiety Disorders in Adults. Image Credit ...
All adults under age 65 should be screened for anxiety, according to the influential US Preventive Services Task Force, which issued new draft guidelines last month. The guidelines, which help guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results